IQoro, a treatment device for swallowing dysfunction and acid-reflux based diseases, will be added to the Drug Tariff from May 1st this year. It has previously been used by around 75,000 individuals that have self-purchased, and by SLTs and neuro-rehab clinicians in 40 or more NHS trusts.
IQoro is a simple hand-held device that is used for 30 seconds per session, three times per day.
It is inserted pre-dentally and pulled forwards to create a low pressure in the oral cavity and stimulate all the 148 muscles involved in a normal swallow. The sensory cranial nerves in the mouth are stimulated to send intense afferent signals to the brain stem, thus invoking a sensory motor reflex arc that exercises and strengthens muscles beyond the command of voluntary system. The training effect promotes neuroplasticity in those patients with neurological conditions.